Accéder au contenu
Merck

A subthreshold synaptic mechanism regulating BDNF expression and resting synaptic strength.

Cell reports (2021-08-05)
Patricia M Horvath, Natali L Chanaday, Baris Alten, Ege T Kavalali, Lisa M Monteggia
RÉSUMÉ

Recent studies have demonstrated that protein translation can be regulated by spontaneous excitatory neurotransmission. However, the impact of spontaneous neurotransmitter release on gene transcription remains unclear. Here, we study the effects of the balance between inhibitory and excitatory spontaneous neurotransmission on brain-derived neurotrophic factor (BDNF) regulation and synaptic plasticity. Blockade of spontaneous inhibitory events leads to an increase in the transcription of Bdnf and Npas4 through altered synaptic calcium signaling, which can be blocked by antagonism of NMDA receptors (NMDARs) or L-type voltage-gated calcium channels (VGCCs). Transcription is bidirectionally altered by manipulating spontaneous inhibitory, but not excitatory, currents. Moreover, blocking spontaneous inhibitory events leads to multiplicative downscaling of excitatory synaptic strength in a manner that is dependent on both transcription and BDNF signaling. These results reveal a role for spontaneous inhibitory neurotransmission in BDNF signaling that sets excitatory synaptic strength at rest.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Désoxyribonucléase I from bovine pancreas, Type IV, lyophilized powder, ≥2,000 Kunitz units/mg protein
Sigma-Aldrich
Actinomycin D, from Streptomyces sp., ~98% (HPLC)
Sigma-Aldrich
Cytosine β-D-arabinofuranoside hydrochloride, crystalline
Sigma-Aldrich
Picrotoxin, powder
Sigma-Aldrich
Anticorps anti-phospho-CREB (Ser133), Upstate®, from rabbit
Sigma-Aldrich
(+)-Bicuculline, ≥97.0% (TLC)